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Autophagy is known to be important in presentation
of cytosolic antigens on MHC class II (MHC II).
However, the role of autophagic process in antigen
presentation in vivo is unclear. Mice with dendritic
cell (DC)-conditional deletion in Atg5, a key autoph-
agy gene, showed impaired CD4+ T cell priming after
herpes simplex virus infection and succumbed to
rapid disease. The most pronounced defect of
Atg5/ DCs was the processing and presentation
of phagocytosed antigens containing Toll-like
receptor stimuli for MHC class II. In contrast, cross-
presentation of peptides on MHC I was intact in the
absence of Atg5. Although induction of metabolic
autophagy did not enhance MHC II presentation,
autophagic machinery was required for optimal
phagosome-to-lysosome fusion and subsequent
processing of antigen for MHC II loading. Thus, our
study revealed that DCs utilize autophagic ma-
chinery to optimally process and present extracel-
lular microbial antigens for MHC II presentation.INTRODUCTION
Classical pathways of antigen presentation involve peptides
derived from intracellular and extracellular antigens to be pre-
sented in the context of MHC class I (MHC I) and MHC II, which
are recognized by cognate CD8+ and CD4+ T cells, respectively
(Trombetta and Mellman, 2005). However, in specialized
antigen-presenting cells such as dendritic cells (DCs), extracel-
lular antigens are processed for presentation in the context of
MHC I molecules via cross-presentation pathway (Heath et al.,
2004). Conversely, several lines of evidence indicate that intra-
cellular antigens can also be processed and presented onMHC II molecules (Brazil et al., 1997; Chen et al., 1998; Do¨rfel
et al., 2005; Gue´guen and Long, 1996; Jacobson et al., 1989;
Jaraquemada et al., 1990; Lich et al., 2000; Nimmerjahn et al.,
2003; Paludan et al., 2005; Qi et al., 2000; Zeng et al., 2001).
Recent studies suggested the involvement of autophagy in
MHC II presentation of intracellular antigens (Levine and Deretic,
2007; Schmid and Mu¨nz, 2007). By using pharmacological inhib-
itors of the class III PI3 kinase, 3-methyladenine (3-MA) and
Wortmannin, MHC II presentation of peptides derived from
ectopically expressed complement C5 protein was shown to
be impaired in mouse macrophage and B cell lines (Brazil
et al., 1997). MHC II presentation of peptides derived from
a tumor antigen, Mucin gene 1, and Neomycin phosphotransfer-
ase II, was also decreased when autophagy was inhibited by
3-MA and Wortmannin (Do¨rfel et al., 2005; Nimmerjahn et al.,
2003). Another report demonstrated that the MHC II presentation
of nuclear antigen 1 of EBV (EBNA1) is reduced by siRNA-medi-
ated knockdown of Atg12, an essential protein involved in
autophagosome formation. Electron microscopy analysis indi-
cated that EBNA1 accumulated in autophagosomes in EBV-
transformed B cell lines (Paludan et al., 2005). The same group
demonstrated that delivery of a model antigen, influenza matrix
protein 1 (MP1), to the autophagosome enhanced MHC II
presentation. Upon fusion of MP1 to LC3, a mammalian homolog
of Atg8 that is inserted into autophagosomal membrane, presen-
tation of MP-1 on MHC class II to MP1-specific CD4+ T cells was
enhanced by up to 20-fold, whereas MHC I presentation of the
same antigen to MP-1-specific CD8+ T cells was not affected.
This study demonstrated that cytosolic antigens could be deliv-
ered to the MHC II processing compartment via autophagy for
enhanced presentation to CD4+ T cells (Schmid et al., 2007).
Although these reports collectively demonstrated the impor-
tance of autophagy in vitro, contribution of autophagic delivery
of antigens in CD4+ T cell priming in vivo remains unclear.
To examine the requirement for Atg5 in the initiation of immune
responses in vivo, we generated Atg5/ neonatal liver chimera
that lack Atg5 gene in hematopoietic compartment, and CD11c-
Cre 3 Atg5flox/flox conditional gene-deleted mice (DC-Atg5/)Immunity 32, 227–239, February 26, 2010 ª2010 Elsevier Inc. 227
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In Vivo Role of Atg5 in Antigen Presentationthat selectively lack Atg5 in conventional DCs (cDCs). With these
mice, we examined the requirement for autophagy and Atg5 in
antigen presentation by cDCs leading to priming of CD4+ T cell
responses in vivo. We showed that innate immune recognition,
antigen capture, migration, maturation, and cytokine production
remained intact in Atg5-deficient cDCs. However, Atg5 and
other proteins required for autophagy were found to be essential
for optimal processing and presentation of a variety of forms of
phagocytosed antigens containing TLR agonists. Our data
provide in vivo evidence of the requirement for Atg5-dependent
process in antigen presentation to CD4+ T cells and revealed an
important role of the autophagic machinery in processing and
presentation of extracellular microbial antigens in DCs.
RESULTS
Impaired CD4+ T Cell Priming by Atg5-Deficient APCs
Atg5 is an essential protein required for autophagosomes forma-
tion (Mizushima et al., 2001). Because Atg5-deficient mice are
incapable of surviving beyond 1 day of life (Kuma et al., 2004),
we generated Atg5/ hematopoietic cells from lethally irradi-
ated wild-type (WT) mice reconstituted with liver cells from the
Atg5/ neonates. Upon full reconstitution, we confirmed that
all hematopoietic cells lacked the Atg5 gene by quantitative
PCR (Lee et al., 2007). Such mice reconstituted hematopoietic
compartments including cDCs and T cells in the spleen, lymph
nodes, and bone marrow (Figure S1 available online). After
mucosal HSV-1 infection, robust T helper 1 (Th1) cell responses
are induced in WT mice (Lee et al., 2009). We examined CD4+
T cell activation in Atg5/ chimeras after intravaginal (ivag)
infection with HSV-1. After 7 days, iliac draining lymph nodes
were isolated and CD4+ T cells were purified and cocultured
with WT antigen-presenting cells (APCs) in the presence of viral
antigen. Interferon-g (IFN-g) secretion from CD4+ T cells, as well
as the number of cells secreting IFN-g, in the Atg5/ chimeric
hosts were significantly reduced compared to the WT control
(Figure 1A). It has been reported that T cells have a survival
defect in Atg5/ mice (Pua et al., 2007; Stephenson et al.,
2009). In order to isolate the effect of Atg5 deficiency on cDCs,
we purified cDCs from the draining lymph nodes of HSV-1-in-
fected WT or Atg5/ chimeric mice at day 3 postinfection (p.i.)
and assessed their ability to stimulate HSV-specific CD4+
T cells in the absence of exogenously added antigens. We found
a significant reduction in the ability of Atg5/ DCs to elicit IFN-g
production from WT effector Th1 cells ex vivo compared to the
DCs from the WT / WT chimera (Figure 1B). The number of
CD4+ T cells secreting IFN-g was also significantly reduced
when Atg5/ DCs were used as APCs (Figure 1B).
Next, the ability of WT T cells to be primed by Atg5/ APCs
was examined in vivo after adoptive transfer of WT OT-II cells
into Atg5/ chimeras. These mice were infected with OVA-ex-
pressing HSV-2 (Dobbs et al., 2005) intravaginally (Figure 1C)
or with OVA-expressing Listeria monocytogenes (Pope et al.,
2001) intravenously (Figure 1D), and proliferation of OT-II cells
were monitored by CFSE dilution. These data demonstrated
that T cells failed to undergo appropriate priming and prolifera-
tion upon stimulation by Atg5/ APCs in vivo. To examine the
DC-intrinsic effect of Atg5 deficiency, splenic cDCs from naive
WT and Atg5/ chimeras were sorted by flow cytometry and228 Immunity 32, 227–239, February 26, 2010 ª2010 Elsevier Inc.injected along with HSV-1 intradermally into WT hosts. Seven
days later, CD4+ T cells response in the draining lymph nodes
was assessed. Although intradermal injection of HSV-1 alone
resulted in weak Th1 cell responses through presentation by
endogenous DC population, a 5-fold increase in Th1 cell induc-
tion was seen when WT cDCs were injected together (Figure 1E).
In contrast, only a moderate increase in Th1 cell responses was
detected in mice receivingAtg5/ cDCs (Figure 1E). Thus, these
results suggested that Atg5 is required for cDCs to prime CD4+
T cell responses in vivo after HSV-1 and Listeria infections.
DC-Specific Atg5/ Mice Fail to Prime Antiviral Th1
Cells and Succumb to HSV-2 Infection
To provide definitive evidence for the in vivo role of autophagic
machinery in antigen presentation by cDCs, and to gain insights
into the physiological importance of T cell priming via this
pathway, we generated CD11c-Cre 3 Atg5flox/flox conditional
gene-deleted mice (DC-Atg5/), which are specifically defec-
tive in autophagy in DCs. We have confirmed that CD11c-Cre
is expressed specifically in cDCs (Figure S2; Stranges et al.,
2007). After intravaginal infection with HSV-2, iliac draining
lymph node was isolated 7 days later, and CD4+ T cells were
purified and cocultured with WT APCs in the presence of viral
antigen. Th1 cell responses in the DC-specific Atg5/ mice
were significantly reduced compared to WT mice (Figure 2A).
Immune protection against HSV-2 is mediated in a CD4+
T cell-dependent manner (Harandi et al., 2001; Milligan et al.,
1998). To determine the importance of the Atg5-dependent
pathway in DCs in the generation of protective Th1 cell immunity,
we next challenged the DC-Atg5/ mice with a lethal dose of
HSV-2 and followed their survival and pathology. In the absence
of Atg5 in DCs, IFN-g secreted from CD4+ T cells between days 4
and 7 after infection (Milligan and Bernstein, 1997) was virtually
absent in the vaginal secretion (Figure 2B), and mice sustained
more severe disease (Figure 2C) and succumbed to HSV-2 infec-
tion more rapidly compared to WT mice (Figure 2D). Thus, taken
together, these data indicated a critical in vivo role of Atg5-
dependent process in antigen presentation by DCs to prime
protective antiviral Th1 cell responses.
Intact Migration and Innate Responses by Atg5/ DCs
Next, we examined the requirement for Atg5 in pathways
involved in T cell activation by DCs. DC migration is pivotal for
the initiation of cellular immune responses. Activated DCs upre-
gulate CCR7 and migrate into secondary lymphoid organs in
order to prime naive lymphocytes (Dieu et al., 1998; Fo¨rster
et al., 1999). To examine the contribution of Atg5 in DC migration
in vivo, we examined the ability of endogenous skin DC popula-
tions to migrate to the draining lymph nodes after a standard
FITC painting protocol. Thus, WT or Atg5/ chimeras were
painted with 1% FITC solution (acetone:dibutyl phthalate = 1:1)
and at 72 hr, migration of FITC+ DCs in the draining lymph nodes
was analyzed by flow cytometry. These analyses revealed no
defects in the ability of Atg5/ DCs to migrate from the skin to
the lymph nodes (Figure 3A).
After their migration into the lymph node, DCs induce differen-
tiation of naive T cells into effector cells. This process requires
at least three signals: cognate peptide presented in the context
of MHC molecules, costimulatory signals, and cytokines.
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Figure 1. Atg5-Deficient DCs Induce Impaired CD4+ T Cell Responses In Vivo
(A and B) WT/WT (WT) and Atg5//WT (Atg5/) chimeras were infected with 106 PFU of HSV-1 ivag.
(A) Seven days later, purified CD4+ T cells from the draining lymph nodes were cocultured with splenocytes in the presence or absence of heat-inactivated (HI)
HSV-1 for 48 hr (right) or for 72 hr (left).
(B) Three days later, the draining lymph node DCs were purified and cocultured for 72 hr with CD4+ T cells isolated from day 7 ivag WT HSV-1-infected mice.
No exogenous viral antigens were added.
(A and B) IFN-g secretion was measured by ELISA (left) and IFN-g-secreting T cells were enumerated by ELISPOT (right).
(C and D) 1,000,000 CFSE-labeled CD45.1+ OT-II CD4+ T cells were adoptively transferred to WT or Atg5/ chimeras 1 day prior to infection. Five days after (C)
ivag infection with 106 PFU of HSV-2-OVA or (D) i.v. infection with 53 105 CFU of Listeria-OVA, OT-II cells from the draining iliac lymph nodes (HSV-2-OVA) and
spleen (Listeria-OVA) were analyzed for CFSE dilution by flow cytometry.
(E) Sorted WT or Atg5/ splenic DCs (53 105) along with 106 PFU of HSV-1 were injected intradermally into naive WT mice. A third group of mice received HSV-1
intradermally in the absence of DCs. Seven days later, CD4+ T cells from draining brachial lymph nodes were isolated and cocultured with splenic APCs in the
presence of HI HSV-1 for 72 hr. IFN-g production by CD4+ T cells was assessed by ELISA.
**p% 0.01; *p < 0.05 relative to WT (Student’s t test). These results are representative of three similar experiments. Error bars indicate SD; n = 3.
Immunity
In Vivo Role of Atg5 in Antigen PresentationExpression of costimulatory molecules CD86 and CD40 mole-
cules as well as MHC II was comparable in the Atg5/ and
WT DCs at steady state (Figure 3B). In addition, both MHC II
and costimulatory molecules were upregulated in response to
HSV-1 infection comparably between Atg5/ and WT DCs
(Figure 3B). To examine whether HSV-infected WT and Atg5/
DCs have similar capacity to present antigens on MHC II, we
pulsed HSV-infected DCs with exogenous peptide OVA323-339
and used them to stimulate OT-II cells. OT-II cells underwent
similar extent of proliferation when WT or Atg5/ DCs were
used as APCs (Figure 3C), indicating that maturation of DCs is
not affected by the absence of Atg5 in HSV-infected DCs. Both
WT and Atg5/ cDCs were equally infected by HSV-1 in vitro
(Figure S3). In addition, secretion of cytokines, IL-12p40, IL-6,
and TNF-a by HSV-infected Atg5/ cDCs was similar to thoseof WT cDCs (Figure 3D). No difference in the mRNA expressions
corresponding to these cytokines was detected (Figure 3E).
These results indicated that Atg5 is not necessary for cytokine
production upon innate recognition of HSV-1 in cDCs, consistent
with our previous study (Lee et al., 2007). In addition, Atg5
deficiency does not affect the ability of cDCs to migrate or to
upregulate costimulatory molecules and MHC II.
Atg5-Deficient DCs Have Normal Endocytic
and Phagocytic Capacity
Thus far, our data indicate that Atg5/ DCs have no defect in
innate recognition, migration, costimulation, MHC expression,
or cytokine secretion in response to HSV-1 infection. Yet, these
cells had an impaired capacity to stimulate CD4+ T cells in vivo.
Our previous study indicated that DCs responsible for CD4+Immunity 32, 227–239, February 26, 2010 ª2010 Elsevier Inc. 229
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Figure 2. DC-Specific Atg5/ Mice Fail to Mount
Protective Immunity against HSV-2 Challenge
(A) CD11c-Cre3 Atg5flox/flox (DC-Atg5/) mice were infected
with 106 PFU of TK HSV-2 ivag. Seven days later, IFN-g
secretion from draining lymph node CD4+ T cells was
analyzed.
(B–D) DC-Atg5/ mice were infected with 103 PFU of WT
HSV-2 ivag. IFN-g in the vaginal secretion on the indicated
days after infection (B), mean clinical scores (C), and survival
(D) are shown.
Error bars represent SEM of five mice per group. **p % 0.01;
*p < 0.05 relative to WT (Student’s t test for A–C and Logrank
test for D). These results are representative of three similar
experiments.
Immunity
In Vivo Role of Atg5 in Antigen PresentationT cell priming in the lymph node after vaginal HSV-2 infection are
not infected by the virus, but rather take up viral antigens from
the infected vaginal keratinocytes in vivo (Zhao et al., 2003).
Thus, to test the possibility that Atg5 is required for uptake of
antigens, we examined the endocytic ability of Atg5/ DCs for
different forms of antigens ex vivo. To probe the pinocytosis-
mediated uptake of soluble antigen, Atg5/ splenic cDCs
were incubated with OVA conjugated to the pH-insensitive fluo-
rochrome Alexa Fluor 488. Both WT and Atg5/ DCs captured
comparable amounts of OVA-Alexa 488 in a dose-dependent
manner (Figure 4A). Next, to examine the phagocytic ability of
DCs from Atg5/ mice, we incubated splenic cDCs with synge-
neic apoptotic MHC II-deficient splenocytes labeled with the
membrane dye PKH26. After 3 hr incubation at 37C, both WT
and Atg5/ splenic cDCs showed similar uptake of splenocytes
(Figure 4B). Nonspecific binding, as demonstrated either by
incubation at 4C or by treatment with cytochalasin D, an inhib-
itor of actin polymerization, was less than 7% in both WT and
Atg5/ splenic cDCs. These data indicated that cDCs do not
require Atg5 for endocytic or phagocytic uptake of exogenous
antigens.
Atg5 Is Required for Optimal Processing
and Presentation of Antigens for MHC II by DCs
Autophagy has been shown to contribute to the processing and
presentation of cytosolic antigens (Ags) (Brazil et al., 1997; Do¨rfel
et al., 2005; Nimmerjahn et al., 2003; Paludan et al., 2005;
Schmid et al., 2007). Thus, to examine the importance of autoph-
agy in presentation of cytosolic Ag, OVA was introduced into the
cytosol of DCs after infection with OVA-expressing Listeria
monocytogenes (Pope et al., 2001). A significant decrease in
OT-II T cell proliferation was seen when T cells were stimulated
by Atg5/ DCs compared to WT DCs (Figure 5A) despite the
similar levels of bacterial infection in these groups (Figure S4A).
This reduced ability of the Atg5/ DCs to present OVA peptide
from Listeria-OVA in vitro was consistent with the lower prolifer-
ation of OT-II cells induced in the Atg5/ host upon infection
with Listeria-OVA in vivo (Figure 1D). Therefore, DC presentation
of peptides derived from a cytosolic bacteria-derived Ag was230 Immunity 32, 227–239, February 26, 2010 ª2010 Elsevier Inc.moderately impaired in the absence of Atg5. These
data indicated that canonical autophagy contrib-
utes to presentation of cytosolic microbial antigens
on MHC II by DCs.Given that APCs responsible for priming T cell immunity to
genital HSV-2 infection are tissue-migrant DCs that have
acquired extracellular viral antigens (Zhao et al., 2003), we
hypothesized that the phenotype of Atg5/ DCs (Figures 1
and 2) reflect the deficiency of DCs to process and present
extracellular viral antigens to CD4+ T cells. To dissect this possi-
bility, we examined the ability of Atg5/ DCs to process and
present various forms of extracellular antigens to CD4+
T cells. We already ruled out an intrinsic and general defect in
the ability of Atg5/ DCs to present peptide on MHC II and
activate CD4+ T cells (Figure 3C). First, to examine the ability
of DCs to process and present soluble Ags, DCs were first incu-
bated with OVA and then naive purified OVA-specific OT-II cells
were added to the culture. We found a slight reduction in the
capacity of Atg5/ DCs to stimulate proliferation of OT-II cells
compared to WT DCs (Figure 5B). However, this difference was
not statistically significant except at the highest Ag doses in all
repeated experiments. To determine whether this slight differ-
ence could be attributed to an unexpected toxicity of OVA on
Atg5/ DCs, we carried out a parallel experiment in which
the same set of DCs were used to stimulate OT-I cells. In
contrast to MHC II presentation, Atg5/ DCs had no observ-
able defect in MHC I presentation of soluble OVA (Figure 5C).
These data excluded the possibility of OVA toxicity or intrinsic
defects in Atg5/ DCs in antigen uptake, survival, or costimu-
lation.
Next, the ability of DCs to present peptide on MHC II after
phagocytic uptake of antigens was assessed. We examined
presentation of apoptotic cell-associated antigen. To restrict
antigen presentation to DCs alone, we incubated WT and
Atg5/ DCs with irradiated OVA-loaded MHC II-deficient sple-
nocytes. Presentation of cell-associated OVA was markedly
diminished in the Atg5/ DCs compared to WT DCs (Figure 5D).
However, Atg5/ DCs demonstrated no defects in cross-
presentation of apoptotic cell-associated antigen on MHC I as
detected by OT-I cells (Figure 5E). A previous study indicated
that phagosomes containing TLR ligands utilize autophagic
machinery to facilitate phagosome fusion with lysosomes,
leading to rapid acidification and enhanced killing of the ingested
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Figure 3. Intact Migration and Innate Responses in Atg5/ DCs
(A) To track endogenous DC migration, 1% FITC solution (acetone:dibutyl phthalate = 1:1) was painted on the back skin of the indicated chimera. At 72 hr, draining
brachial lymph nodes were isolated and FITC content within the CD11c+ MHC II+ DCs was analyzed.
(B) MACS-purified DCs from WT or KO chimera were left untreated or infected with HSV-1 (MOI = 1) for 18 hr. The expression of MHC II, CD40, and CD86
molecules were analyzed by flow cytometry.
(C) OT-II T cells were cultured with the HSV-1-infected splenic DCs (as in A) in the presence of 10 ng/ml OVA323-339 peptides for 72 hr at 37
C. T cell proliferation
was measured by 3H thymidine incorporation.
(D and E) Sorted splenic WT and Atg5/ DCs (105) were infected with HSV-1 (MOI = 5). After 18 hr, IL-12p40, IL-6, and TNF-a levels were measured from
supernatants by ELISA (D) or by quantitative RT-PCR (E). These results are representative of three similar experiments. Error bars indicate SD; n = 3.
Immunity
In Vivo Role of Atg5 in Antigen Presentationorganism (Sanjuan et al., 2007). Because most commercially
available OVA is contaminated with LPS (Eisenbarth et al.,
2002), we examined MHC II presentation of phagocytosed
antigen devoid of TLR agonists in Atg5/ DCs. Irradiated
apoptotic splenocytes from C3H/HeN mice (I-Ea+), coated with
LPS or not, were given to WT or Atg5/ DCs and the extent of
Ea presentation on I-Ab was assessed by the Y-Ae antibody
(Figure S4B; Murphy et al., 1992). These data indicated that in
the absence of TLR engagement, both WT andAtg5/ DCs pre-
sented equivalent amounts of MHC II peptide complex on their
cell surface, whereas MHC II presentation of LPS-coated
apoptotic cells was enhanced only in WT but not Atg5/ DCs.
Collectively, these data indicated that whereas uptake of Ags,
activation of DCs, and cross-presentation to MHC I occur nor-
mally in Atg5/ DCs, these cells have a pronounced defect in
MHC II processing pathways for phagocytosed antigens that
contain TLR agonists.Autophagic Machinery Facilitates MHC II Presentation
of Phagocytosed Antigens by DCs
Because Atg5 protein has been reported to serve autophagy-
independent functions (Jounai et al., 2007; Yousefi et al., 2006;
Zhao et al., 2008), we examined whether other key components
of autophagic machinery are required for antigen processing and
presentation by DCs. To this end, we employed two strategies.
First, we used well-known inhibitors of autophagy, 3 methylade-
nine (3MA) and Wortmannin (WM). At doses of 3MA (1–10 mM)
and Wortmannin (10–100 nM) that are known to specifically
inhibit autophagy (Blommaart et al., 1997; Seglen and Gordon,
1982), presentation of phagocytosed antigen was significantly
reduced. In contrast, the same doses of these inhibitors did
not affect exogenous peptide presentation on MHC II (Fig-
ure S5A). Second, to more specifically inhibit the functions of
autophagic machinery, we used siRNA knockdown of Atg7 or
Atg12 to block the function of autophagic machinery in primaryImmunity 32, 227–239, February 26, 2010 ª2010 Elsevier Inc. 231
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Figure 4. Unimpaired Endocytosis and Phagocytosis inAtg5/DCs
Purified splenic DCs from WT or Atg5/ chimeras were incubated with the
indicated amounts of OVA-Alexa 488 for 1 hr at 4C or 37C (A) or irradiated
PKH26-labeled MHC II/ splenocytes on ice or at 37C in the presence or
absence of 10 mM cytochalasin D for 3 hr (B). Uptake of OVA (A) or PKH26-
labeled apoptotic cells (B) by DCs was determined by flow cytometry. The
results shown are representative of three independent experiments. Numbers
indicate percentages.
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In Vivo Role of Atg5 in Antigen PresentationDCs. We examined the ability of DCs that have reduced Atg7 or
Atg12 to process and present viral Ag from primary kerataino-
cytes that have been infected with HSV-2-expressing OVA
(Dobbs et al., 2005), to mimic the situation of Ag presentation
in vivo. Blockade of the function of autophagic machinery
resulted in a significant reduction of MHC II peptide presentation
from HSV-2-infected cells (Figure S5B). To determine whether
signs of metabolic autophagy are detected in DCs after phagocy-
tosis, WT and Atg5/ DCs were fed LPS-coated latex beads,
and at various time points, indicators of metabolic autophagy,
lipidated LC3 and p62 (Klionsky et al., 2008), were assessed.
Although lipidated LC3 was absent in Atg5/ DCs, WT DCs
underwent constitutive autophagy (Figure S5C; Schmid et al.,
2007). However, phagocytosis of LPS-coated beads did not alter
the total level of cytosolic autophagy as indicated by constant
levels of LC3-II and p62 (Figure S5C). Next, we tested whether
induction of canonical autophagy enhances MHC II presentation
of phagocytosed antigens. To this end, we induced autophagy by
rapamycin treatment or starvation by an established method
(Sanjuan et al., 2007) prior to the addition of LPS-Ea-coated latex232 Immunity 32, 227–239, February 26, 2010 ª2010 Elsevier Inc.beads. Peptide presentation on MHC II as measured by Y-Ae
antibody (Figure S5D) demonstrated that induction of metabolic
autophagy by rapamycin or starvation failed to enhance MHC II
peptide presentation. If anything, these treatments led to a reduc-
tion in MHC II presentation, even when Ag uptake was normalized
by gating on DCs that have captured a single bead (Figure S5D).
Our data thus far indicated that TLR-phagosome might utilize
autophagic machinery for processing of antigens for MHC II
presentation in DCs without invoking canonical cytosolic au-
tophagy. To directly address this possibility, we analyzed the
membrane surrounding the TLR-phagosome by transmission
electron microscopy (TEM). Lysosomal contents were labeled
with magnetic beads and were visualized by the presence of
electron-dense material (Figure 6, black arrowheads). DCs
were given LPS-OVA-coated latex beads and chased for
20 min. This time point was chosen based on the fact that LC3
recruitment to the phagosome was reported to begin around
20 min postingestion (Sanjuan et al., 2007). At this time point,
lysosomal membranes fusing with the bead-containing phago-
some were clearly detected (Figure 6, white arrows). However,
we failed to detect any double membrane structures surrounding
the phagosome. These data are consistent with previously pub-
lished report with RAW264.7 macrophage cell line (Sanjuan
et al., 2007) and further emphasize that in DCs, phagosomal
maturation requires Atg5-dependent process that does not
involve double membrane structure around the phagosomes.
Thus, these data suggested that a process that depends on
the components of autophagic machinery, but not canonical au-
tophagy, is required in DC presentation of peptide on MHC II.
Impaired Phagosome-to-Lysosome Fusion
in Atg5/ DCs
In an effort to determine the mechanism by which the autophagic
machinery facilitates processing of phagocytosed antigens, we
first examined the kinetics and extent of peptide loading onto
MHC II with a pulse-chase analysis after phagocytosis of
Ea-LPS-bound-latex beads. These results demonstrated that
the emergence of the Ea peptide-MHC II complex as detected
by the Y-Ae antibody was delayed in both the intracellular
compartment and at the cell surface in Atg5/ DCs (Figure 7A).
Second, to rule out the possibility that the defect in antigen
presentation might be related to defective trafficking of antigens,
we performed a confocal microscopy experiment to localize the
phagocytosed antigen and MHC II. These analyses revealed that
antigens (yeast particles) are taken up and delivered to the MHC
II loading compartment normally in Atg5/ DCs (Figure 7B).
Third, we asked whether the decreased peptide presentation
on MHC II in Atg5/ DCs could be a result of enhanced or
reduced degradation of antigens within the phagosome. If
Atg5/ DCs degrade phagocytosed antigens too rapidly and/
or extensively for MHC II loading, we should be able to rescue
their phenotype by adding increasing concentrations of protease
inhibitors. To this end, we inhibited the activity of lysosomal
proteases with a combination of leupeptin and pepstatin (Jancic
et al., 2007). Addition of protease inhibitors failed to revert the
defective presentation phenotype of Atg5/ DCs (Figure 7C).
In addition, the kinetics of degradation of phagocytosed
antigens in Atg5/ DCs was severely delayed compared to
WT DCs (Figure S6A). These results indicated that the
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Figure 5. Atg5 Is Necessary for Antigen Processing
for MHC II, but Not MHC I
(A) WT or Atg5/ DCs infected with Listeria-OVA were cocul-
tured with OT II T cells for 72 hr at 37C.
(B and C) OT-II (B) or OT-I (C) cells were incubated in the pres-
ence of purified splenic DCs loaded with indicated amounts of
soluble OVA.
(D) Purified splenic DCs were loaded with the indicated
numbers of OVA-coated MHC II-deficient splenocytes and
incubated with OT-II cells for 72 hr at 37C.
(E) Purified splenic DCs were loaded with the indicated
numbers of OVA-coated MHC I-deficient splenocytes and
incubated with OT-I cells for 72 hr at 37C. T cell proliferation
was measured by 3H incorporation.
**p% 0.01; *p < 0.05, relative to WT (Student’s t test). These
data are representative of three to six similar experiments.
Error bars indicated SD.
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In Vivo Role of Atg5 in Antigen Presentationphagolysosomes of the Atg5/ DCs have impaired, rather than
excessive, degradative capacity, resulting in less peptide pre-
sented on MHC II.
The defective proteolytic environment of the phagosomes in
Atg5/ DCs could result from (1) a defective lysosomal
compartment, (2) a defect in trafficking of vacuolar ATPases to
acidify the phagosomal compartment, or (3) a defect in delivery
of lysosomal proteases to phagosomes. To test these possibili-
ties, we first measured the pH of both the lysosomes and phag-
osomes in WT and Atg5/ DCs (Figure 7D). These analyses
indicated that lysosomal pH levels in theAtg5/DCs were indis-
tinguishable from those of the WT DCs. Furthermore, both the
kinetics and the extent of acidification was identical in the phag-
osomes of Atg5/ DCs compared to WT DCs, indicating that
trafficking of V-ATPase is intact in the absence of Atg5. To further
examine the possibility that lysosomes might be defective in
Atg5/ DCs, we analyzed the amounts of lysosomal proteases.
Immunoblot analysis of the whole cell lysates revealed that
amounts of cathepsins B, D, L, and S were comparable in WT
and Atg5/ DCs (Figure S6B). Consequently, Ii chain process-
ing was not affected at steady-state (Figure S6B). In addition,
we tested the proteolytic activity of the lysosomal enzymes by
using casein, a generic proteolysis substrate, in a fluorescence
assay that relies on relief of intermolecular quenching as fluores-
cent peptides are released from a highly labeled, internally
quenched protein substrate (Jones et al., 1997). This analysis
revealed that lysosomal proteolytic activity was intact in the
absence of Atg5 (Figure S6C). Thus, collectively, these data
indicated that the lysosomes of Atg5/ DCs are not impaired
with regards to pH maintenance, cathepsins levels, and proteo-
lytic capacity. In addition, acidification of phagosomes in DCs is
unaffected by the absence of Atg5.Immunity 32,These results led us to examine the third poten-
tial explanation for the defective phagosomal
proteolysis in Atg5/ DCs, namely a defective
delivery of lysosomal proteases to the phago-
somes. To test this hypothesis, phagosomes from
WT and Atg5/ DCs were isolated at various
time points after phagocytosis of LPS-coupled
beads, and protease activities were measured
against specific substrates for cathepsins S or Band L. These analyses revealed that Atg5/ DCs have a signifi-
cant defect in cathepsins S, B, and L activity in the phagosome
(Figure 7E). However, the defect in phagolysosomal proteolysis
was not complete and not enough to reduce the steady-state
MHC II levels (Figure 3) or Ii chain processing (Figure S6B), indi-
cating that the reduction in presentation of phagocytosed
antigenic peptide is probably due to a specific defect in the
proteolysis of the phagosomal antigens associated with TLR
agonists (Figure S4B). Finally, to directly examine the rate of
phagosome fusion to lysosome, confocal microscopic analyses
of WT and Atg5/ DCs were carried out at 5, 15, and 30 min
chase after a 5 min pulse with LPS-OVA-coated latex beads.
Although the rate of bead uptake was comparable, Atg5/
DCs were significantly delayed in their ability to fuse phagocy-
tosed beads to the lysosome compared to the WT DCs (Figures
S6D and S6E). Collectively, these data indicated that in the
absence of Atg5, DCs have an impaired capacity to process
and present phagocytosed antigen on MHC II, and such defect
is unrelated to the pH environments of the phagolysosome or
lysosome, but rather, is a result of delayed fusion of phagosome
to lysosome and defective delivery of cathepsins to the MHC II
processing compartments of Atg5/ DCs.
DISCUSSION
Our present study provides evidence that autophagy is required
for processing and presentation of antigens for MHC II presenta-
tion to enhance CD4+ T cell activation in vivo. In the absence of
Atg5 in DCs, the animal failed to mount proper Th1 cell immunity,
succumbing to viral disease and death. We demonstrated that
whereas innate recognition, Ag capture, migration, maturation,
and cytokine secretion by DCs is unimpaired in the absence of227–239, February 26, 2010 ª2010 Elsevier Inc. 233
Figure 6. Absence of Double Membrane Structure around LPS-
Bead-Containing Phagosome in DCs
Lysosomes were labeled with magnetic beads (electron-dense materials).
MACS-purified CD11c+ BMDCs were pulsed with LPS-OVA-latex beads for
20 min. BMDCs were fixed and sectioned for transmission electronic micros-
copy. White arrows indicate lysosomal membranes fusing with the bead-con-
taining phagosome. Black arrowheads indicate lysosomes (labeled with
magnetic beads). Scale bars represent 2 mm in (A) and 1 mm in (B). Results
are representative of three independent experiments.
Immunity
In Vivo Role of Atg5 in Antigen PresentationAtg5, processing and presentation of phagocytosed Ags con-
taining TLR agonists for MHC II is diminished in Atg5/ DCs.
In the absence of Atg5, DCs had a reduced capacity to process
cytosolic antigens for MHC II presentation. This is consistent
with the notion that canonical autophagy delivers cytosolic
antigens to MHC II compartment (Schmid et al., 2007). More
significantly, Atg5/ DCs were impaired in their ability to
process phagocytosed antigen for loading onto MHC II, and
this defect was due to the impaired phagosome-to-lysosome
fusion and delivery of lysosomal proteases to the phagosomes.
Although machinery of autophagy (PI3K, Atg5, Atg7, and
Atg12) was required, metabolic autophagy was neither induced
nor required for enhanced processing of phagocytosed Ag for
MHC II presentation in DCs. Therefore, this study revealed the
importance of autophagic machinery in DCs for facilitating
optimal processing of extracellular antigens containing microbial
signatures and presentation to CD4+ T cells.
In addition to the impaired CD4+ T cell responses, we also
observed significant decrease in the CD8+ T cell responses after
HSV-1 infections in vivo. However, because the induction of CTL
responses to HSV-1 requires CD4+ T help (Jennings et al., 1991),
our data do not distinguish whether the reduced CD8+ T cell
responses represent the requirement for T help, or whether
presentation of antigenic peptide on MHC I also requires autoph-
agy in vivo. Parallel in vitro experiments to probe antigen presen-
tation of various forms of OVA revealed that presentation of
peptides for MHC II, but not MHC I, required Atg5 in DCs.234 Immunity 32, 227–239, February 26, 2010 ª2010 Elsevier Inc.Because infected DCs are rendered incapable of T cell priming
(Kruse et al., 2000; Mikloska et al., 2001; Pollara et al., 2003;
Salio et al., 1999), the results of our current study reflect the
requirement for autophagic machinery in uninfected DCs to
prime naive CD4+ T cells. In addition, recent studies indicate
that in infected cells, autophagy may enhance antigen presenta-
tion to MHC I (English et al., 2009) and MHC II (Leib et al., 2009)
after HSV-1 infection.
HSV-1 encodes ICP34.5, which inhibits autophagy by two
distinct manners—by binding to Beclin-1/Atg6 (Orvedahl et al.,
2007) and by inhibiting the action of PKR by dephosphorylating
eIF2a (Tallo´czy et al., 2002). These anti-autophagic actions of
ICP34.5 result in enhanced viral replication in vivo (Orvedahl
et al., 2007). Our in vitro infection of Atg5/ DCs by TK HSV-
2-OVA exhibited little difference in the extent of infection as
measured by viral titer, albeit slight increase in glycoprotein
expression detected in the Atg5/ DCs at all MOIs tested.
These data are consistent with a previous report indicating that
elimination of the autophagic pathway in mouse embryonic fibro-
blast did not alter the replication of wild-type HSV-1 or ICP34.5
mutants (Alexander et al., 2007). In addition, despite the actions
of ICP34.5, we observed a significant reduction in both CD4+ and
CD8+ T cell priming to HSV-1 in mice deficient in Atg5 in the
hematopoietic compartment or in DCs. These results indicate
that DCs responsible for presenting the viral peptide in vivo are
not directly infected by HSV, and for this reason, the virulence
factor ICP34.5 was unable to inhibit the autophagic machinery
within Ag-presenting DCs.
The precise nature by which Atg5 contributes to antigen
presentation by DCs is unknown. Consistent with previous
studies demonstrating the role of autophagy in delivery of cyto-
solic Ags to the MHC II loading compartment, our data also
showed that cytosolic antigens are presented to MHC II more
efficiently in the presence of Atg5. The requirement of Atg5 in
presentation of cytosolic Ags probably reflects the requirement
for autophagy in delivering antigens to the MHC II loading com-
partment (Levine and Deretic, 2007; Schmid and Mu¨nz, 2007). In
addition to this well-accepted role of autophagy in MHC II
presentation of cytosolic antigens, our data revealed an impor-
tant role of Atg5 in presentation of phagocytosed Ags, and to
a lesser extent, soluble Ags that are associated with PAMPs.
This process depended on autophagic machinery (PI3K, Atg5,
Atg7, and Atg12), but metabolic autophagy was neither induced
nor required for enhanced processing of phagocytosed Ag for
MHC II presentation in DCs. Our data ruled out that such an
Atg5-dependent process relates to dysfunctional lysosomes,
synthesis and maturation of cathepsins, or pH regulation in the
lysosomes or phagosomes. Instead, autophagic machinery
was required for the efficient phagolysosomal fusion and subse-
quent delivery of lysosomal proteases to the phagosomes
containing TLR agonists. These data are consistent with the
demonstration in macrophages that autophagic machinery
promotes the recruitment of LC3 and Beclin-1 to the phagosome
in which TLR is engaged, allowing rapid fusion with lysosome
(Sanjuan et al., 2007). Our study also provides a potential mech-
anism by which TLR-engagement enables MHC II peptide
presentation in DCs (Blander and Medzhitov, 2006). Collectively,
these studies and our current study suggest a model in which
TLR engagement in the phagosome leads to recruitment of
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Figure 7. Atg5 Is Required for Effective Delivery of Lysosomal Proteases to the Phagosome
(A) CD11c+ splenic DCs isolated from WT or Atg5/ mice were incubated with I-Ea-bound latex beads for the indicated time. Cell surface and intracellular levels
of Ea52-68:MHC II complex on DCs that have taken up precisely one bead were analyzed by Y-Ae antibody.
(B) Localization of yeast expressing GFP in WT or Atg5/ BMDCs was analyzed by immuofluorescence confocal microscopy. Percentages of DCs containing
yeast in the MHC II compartment in DCs are plotted. Data are means ± SD.
(C) Presentation of OVA323-339 peptides on MHC II after uptake of irradiated OVA-coated MHC II-deficient splenocytes by WT or Atg5
/ BM DCs was assayed in
the presence of increasing concentrations of the protease inhibitors (leupeptin and pepstatin).
(D) Kinetics of lysosomal and phagosomal pH in WT or Atg5/ BM DCs was analyzed.
(E) Extracts of phagosomes isolated from WT and Atg5/ BM DCs were incubated for the indicated duration of time in the presence of fluorogenic substrate
for cathepsins B and L (B/L) or cathepsins S at the indicated pH. The optimal pH for Cathepsin B/L is pH 5.5, whereas that for cathepsin S is pH 7.4. Substrate
degradation was assayed fluorometrically.
Data are representative of three independent experiments. Error bars indicate SD.
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In Vivo Role of Atg5 in Antigen Presentationautophagic machinery, allowing rapid fusion to the lysosome and
delivery of proteases that cleave antigens efficiently for MHC II
loading.
Whether a similar requirement for autophagic machinery
exists for MHC II peptide presentation by other APCs is
unknown. For example, B cells have been shown to present
endogenous Ags readily in a process largely dependent on
intact autophagosome formation (Brazil et al., 1997; Nimmerjahn
et al., 2003; Paludan et al., 2005; Schmid et al., 2007). Several
tissues, including thymic epithelial cells, podocytes, and gastric
chief cells undergo high constitutive rate of autophagy in
nutrient-rich conditions in vivo (Mizushima et al., 2004). A recent
study indeed revealed the importance of autophagy in presenta-
tion of self-peptide on MHC II by thymic epithelial cells inshaping the CD4+ T cell repertoire (Nedjic et al., 2008). Studies
in this area are expected to reveal the relative involvement of
autophagy in Ag presentation in a variety of immunological
contexts.
Our study demonstrated an important role for autophagic
machinery in processing and presentation of phagocytosed
Ags for MHC II by conventional DCs. These findings provide
in vivo evidence for the importance of autophagic machinery
in MHC II presentation of a variety of antigenic forms by
DCs and have important implications in the design of
vaccines. By utilizing the biology of autophagosome and its
machinery, DCs can be targeted for both optimal innate
activation as well as improved peptide presentation on MHC
molecules.Immunity 32, 227–239, February 26, 2010 ª2010 Elsevier Inc. 235
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In Vivo Role of Atg5 in Antigen PresentationEXPERIMENTAL PROCEDURES
Animals
6- to 8-week-old female C57BL/6 was obtained from National Cancer Institute
(Frederick, MD). Atg5+/ (Kuma et al., 2004), Atg5flox/flox (Hara et al., 2006),
CD11c-Cre Tg (Stranges et al., 2007) MHC II-deficient (H2-Ab1/), MHC
I-deficient (H-2K/D/) (Taconic), C3H/HeN (Taconic), OT-I Rag1/
(Taconic), and OT-II (Jackson) mice were bred in the Yale animal facility. All
procedures used in this study complied with federal guidelines and institutional
policies by the Yale Animal Care and Use Committee.
Neonatal Liver Chimera Generation
Atg5 chimeras were produced as described (Lee et al., 2007). In brief, 2–3 3
106 liver cells from less than 24-hr-old pups born to Atg5+/ parents were
screened for the Atg5 genotype and injected into recipient C57BL/6 mice via
tail vein. Prior to transfer of liver cells, recipient mice were lethally irradiated
with 4.75 Gy of irradiation two times 3 hr apart. This procedure led to complete
chimerism of hematopoietic cells by 8 weeks posttransplantation (Lee et al.,
2007).
Virus, Bacteria, and Infection
HSV-1 KOS, 186syn+ HSV-2, and TK HSV-2 strains were kindly provided by
D. Knipe (Harvard Medical School, Boston, MA). HSV-1 was propagated and
titered by a plaque assay on Vero cells. HSV-2-TK OVA (Dobbs et al., 2005)
and Listeria monocytogenes-OVA (Pope et al., 2001) were gifts from
G. Milligan (University of Texas Medical Branch, Galveston, TX) and L. Lefran-
c¸ois (University of Connecticut Health Center, Farmington, CT), respectively.
Intravaginal virus infection was carried out as previously described with 1 3
106 PFU of HSV-1 or HSV-2 in 10 ml volume (Lee et al., 2009). Upon WT
HSV-2 challenge, the severity of disease was scored (Morrison et al., 1998):
0, no sign; 1, slight genital erythema and edema; 2, moderate genital inflamma-
tion; 3, purulent genital lesions; 4, hind-limb paralysis; 5, premoribund.
Because of humane concerns, the animals were euthanized prior to reaching
moribund state. For intradermal infection, mice were inoculated in the back
skin with 1 3 106 PFU of HSV-1 with or without 5 3 105 sorted DCs in 100 ml
PBS. For Listeria-OVA infection in vivo, a total of 1 3 106 CFSE-labeled
CD45.1+OT-II T cells were intravenously transferred into CD45.2+ congenic
Atg5 chimeras. Twenty-four hours later, these mice were intravenously
infected with 5 3 105 CFU of Listeria-OVA.
CD4+ T Cell Response Assay
Anti-HSV CD4+ T cells were analyzed as previously described (Zhao et al.,
2003). To assess the ability of DCs to present viral Ag ex vivo, 5 3 104 DCs
isolated from the draining lymph nodes of day 3 ivag HSV-1-infected mice
were cocultured with 1 3 105 CD4+ T cells isolated from day 7 ivag HSV-1-in-
fected mice for 72 hr at 37C in the absence of viral antigens. IFN-g production
in supernatants was measured by enzyme-linked immunosorbent assay
(ELISA). For ELISPOT assay, 105 CD4+ T cells were incubated with 105 spleno-
cytes as antigen-presenting cells in the presence of 500 PFU-equivalent of
heat-inactivated HSV-1 in 96-well PVDF membrane plates for ELISPOT (Milli-
pore) that were precoated with IFN-g antibody (AN-18, eBiosciences) for 48 hr
at 37C. The plates were developed with IFN-g antibody (R4-6A2, eBioscien-
ces). IFN-g+ spots were analyzed by ELISPOT reader (CTL Cellular Tech-
nology). To assess the ability of DCs to present viral Ag ex vivo, 5 3 104
DCs isolated from the draining lymph nodes of day 3 ivag HSV-1-infected
mice were cocultured with 1 3 105 CD4+ T cells isolated from day 7 ivag
HSV-1-infected mice for 48 hr at 37C in the absence of viral antigens in
PVDF membrane plates and followed as described above for ELISOPT assay.
Dendritic Cell Isolation and Sorting
The DCs were prepared from spleen and the draining lymph nodes based on
previously described methods (Lee et al., 2009) with slight modifications. To
obtain sufficient DCs from each chimeric mouse for in vitro experiments, 1 3
106 B16 melanoma cells expressing Flt3L (Mach et al., 2000) were injected
into mouse neck ruff 14 days prior to harvest. The spleen and draining lymph
nodes were removed from mice infected for the indicated time periods. To
obtain FACS-sorted DCs, enriched CD11c+ cells were stained with anti-
MHC II-FITC (M5/114.15.2, eBiosciences), anti-PDCA-1-PE (Miltenyi Biotec),236 Immunity 32, 227–239, February 26, 2010 ª2010 Elsevier Inc.anti-B220-PE-Cy5 (RA3-6B2, eBiosciences), and anti-CD11c-APC (HL3, BD
Biosciences) after incubating for 10 min at 4C in the presence of anti-
CD16/32 (2.4G2, BD Biosciences) antibody to block Fc receptors. Stained
cells were sorted by FACS Aria (BD Biosciences, Mountain View, CA). Sorted
splenic CD11c+MHC II+B220PDCA-1 cDCs were more than 98% pure as
assessed by post-sort analyses. Sorted DCs were cultured in RPMI 1640
containing 10% FBS (Invitrogen), 50 mM b-mercaptoethanol, 100 unit/ml
penicillin (Invitrogen), and 100 mg/ml streptomycin (Invitrogen) in 96-well
U-bottom plates (BD Biosciences).
Tracking of Migrant DCs after FITC Painting
Migration of endogenous DC populations was analyzed according to a stan-
dard FITC painting protocol (Macatonia et al., 1987). In brief, mice were anes-
thetized, shaved with hair clipper, and depilated. The depilated areas of the
skin were painted with 1% FITC solution in acetone:dibutyl phthalate (1:1 ratio,
Sigma-Aldrich). The brachial lymph nodes were isolated at 72 hr and single-
cell suspensions were prepared as described above. Isolated lymph node
cells were stained with anti-CD11c (N418, eBioscience)-PE-Cy7 and MHC II
(eBioscience)-Alexa 680 and FITC uptake was analyzed by FACS.
Flow Cytometric Analyses of T Cells and DCs
Enriched DCs were pretreated with anti-CD16/32 (2.4G2) antibody to block Fc
receptors and stained with anti-CD40 (1C10, eBioscience), anti-CD86 (GL1,
eBioscience), anti-CD8a (53-6.7, BD Biosciences), and anti-MHC II (I-Ab, BD
Biosciences). T cells were stained with anti-CD4 (GK1.5, eBioscience) and
anti-CD8a antibodies. To detect Ea52-68: MHC II complex on the surface of
DCs that have taken up LPS-coated Ea-latex bead (4 mm, Invitrogen) (purified
Ea protein with his tag from E. coli was kindly provided by I. Mellman [Genen-
tech]), DCs were stained with Y-Ae-biotin (eBioscience)/SA-PE, anti-MHC II
Alexa 680, and anti-CD11c APC (HL3, BD Biosciences). For intracellular stain-
ing, cell surface Y-Ae was first blocked by purified unlabeled Y-Ae antibody
and DCs were intracellularly stained with anti-Y-Ae-biotin or anti-his-biotin
(abcam) followed by SA-PE after fixation and permeabilization with cyto-fix/
cyto-perm kit (BD Biosciences).
Detection of Cytokines
Levels of IL-12p40, IL-6, and TNF-a were measured with an ELISA kit
(eBiosciences) according to manufacturer’s instruction. For RT-qPCR, total
RNA was extracted by RNA isolation kit (QIAGEN) and cDNA was synthesized
(Invitrogen). The qPCR was performed with SYBR green kit (QIAGEN) on
MX4000 QPCR System according to manufacturer’s instruction (Stratagene,
La Jolla, CA) as previously described (Lee et al., 2007).
Endocytosis and Phagocytosis Assays
To examine endocytic uptake of soluble Ags, MACS-purified DCs were
incubated with OVA conjugated to Alexa Fluor 488 for 1 hr at 37C or on ice.
Cells were washed and stained with anti-CD11c and analyzed by LSR II. To
assess the ability of DCs to phagocytose apoptotic cells, MHC II-deficient
splenocytes were labeled with 2 mM PKH26 (Sigma) for 5 min at room temper-
ature, washed, and irradiated (1500 rads). MACS-purified DCs (2.53 105) were
stained with anti-CD11c Ab and subsequently cocultured with 13 106 PKH26-
labeled splenocytes in the presence or absence of 10 mM cytochalasin D
(MP Biomedicals) for 3 hr at 37C. Cells were washed and analyzed by LSR II.
In Vitro Antigen Presentation Assays
Apoptotic cell-associated OVA was prepared according to a previous report
(Schnorrer et al., 2006). In brief, MHC II-deficient or KbDb double knockout
splenocytes were irradiated (1500 rads), washed, and incubated with 10 mg/
ml OVA for 15 min at 37C. To assess the ability of DCs to present OVA peptide
on MHC II, 1 3 105 DCs were incubated with indicated amounts of OVA-
coated MHC II-deficient splenocytes, soluble OVA, or OVA323-339 peptides.
The Ag-loaded DCs were cocultured with 1 3 105 naive OT-II T cells for
72 hr 37C. T cell proliferation was measured by 3H incorporation after adding
0.5 mCi of thymidine per well starting at 48 hr of incubation. In some experi-
ments, inhibitors of autophagy, 3MA (0.5–1.0 mM) or Wortmannin
(50–100 nM), were added to the DC-T cell coculture. To measure cross-
presentation of OVA on MHC I, 1 3 105 DCs were incubated with indicated
amounts of OVA-coated KbDb double knockout splenocytes or soluble OVA.
Immunity
In Vivo Role of Atg5 in Antigen PresentationThe Ag-loaded DCs were cocultured with 5 3 104 naive OT-I/Rag1/ T cells
for 72 hr 37C. T cell proliferation was measured by 3H thymidine incorporation
after adding 0.5 mCi of thymidine per well starting at 48 hr of incubation.
Immunofluorescence Assay and Transmission Electron Microscopy
WT or Atg5/ BM DCs were mounted on 0.5% alcian blue-coated coverslip
and were pulsed with yeast expressing GFP for 15 min. DCs were washed
and chased for 3 hr. For the analysis of the fusion of phagosomes and
lysosomes, CD11c+ BM DCs were attached on coverslips and were labeled
with LysoTracker (Invitrogen). DCs were pulsed with LPS-OVA-coated latex
beads conjugated with Alexa 488 (Invitrogen) for 5 min and then chased
for 5, 15, and 30 min. DCs were fixed with 4% paraformaldehyde for 20 min,
permeabilized in PBS/0.05% saponin/1% BSA for 30 min, washed, and then
stained for MHC II. Cells were analyzed by confocal microscopy. Immunoflu-
orescence images were acquired with Zeiss confocal microscope (LSM 510).
For transmission electron microscopy, CD11c+ BM DCs were first labeled with
anti-CD11c magnetic beads (Miltenyi Biotec) to label lysosomes (5 hr chase),
then incubated with LPS-OVA-coated latex beads (4 mm) for 20 min. Cells were
washed with cacodylate buffer (pH 7.4) and then fixed with 1% osmium
tetroxide in 0.1 M sodium cacodylate buffer (pH 7.4). Cells were rinsed three
times in 50 mM sodium maleate buffer (pH 5.2) and then stained in 2% uranyl
acetate in 50 mM sodium maleate buffer for 1 hr in the dark. Cells were then
rinsed three times in HPLC-grade water and then dehydrated in 50%, 70%,
90%, and 100% ethanol. The ethanol was replaced with propylene oxide
and then the coverslips were embedded with Embed-812 (Electron Micros-
copy Sciences). Thin sections were cut with a Reichert Ultracut E ultramicro-
tome, placed on copper grids, and then stained for 10 min in 5% uranyl acetate
in 50% methanol and 2 min in Reynold’s lead citrate solution. Cells were
analyzed on a Tecnai 12 Biotwin transmission electron microscope. Images
are analyzed with iTEM (Olympus Soft Imaging Solutions).
siRNA Knockdown
Primary mouse keratinocytes cultured in 6-well plates were infected with
HSV-OVA (MOI = 5) for 20 hr. Infected keratinoctyes were UV irradiated and
cocultured with 1 3 106 WT or Atg5/ CD11c+ DCs that were transfected
with 10 ml/well siRNA specific for Lamin A/C (irrelevant control), Atg7, or
Atg12 (Santa Cruz) in 5 ml/well lipofectamine on 24-well plate for 18 hr. DCs
were enriched by LSM lymphocyte separation medium. The purified 1 3 105
DCs were cocultured with 1 3 105 OT-II T cells for 72 hr. 3H thymidine was
added for extra 24 hr to measure T cell proliferation.
Phagosome Purification
DCs were incubated with 2.8 mm magnetic beads conjugated with streptavidin
(Invitrogen) bound to biotin-LPS (Invivogen) for the indicated duration of time.
DCs were then disrupted in homogenization buffer (250 mM sucrose, 3 mM
imidazol [pH 7.4]) and 200 mg/ml DNase (Roche), as described (Jancic et al.,
2007). After homogenization, phagosomes were isolated by a magnet and
were washed three times in cold PBS. The purified phagosomes were pelleted
and extracts were prepared in lysis buffer (1% Triton X-100, 25 mM NaCl in
PBS). After 15 min at 4C, the lysates were centrifuged to remove the magnetic
beads. Phagosomal extracts were used for measurement of cathepsin activity.
pH Measurement
Levels of pH of the lysosomes and phagosomes were measured as previously
described (Steinberg et al., 2007) with minor modifications. For lysosomal pH
measurement, WT or Atg5/ BM DCs were plated on cover slides. The DCs
were chased either for 1 or 2 hr to adhere and spread on the poly-lysine-coated
glass after pulsing with Oregon green 488-dextran. pH was calculated by the
ratio of 490 nm/440 nm fluorescence intensity. For phagosomal pH measure-
ment, WT or Atg5/ BM DCs were pulsed with FITC-conjugated zymosan-
beads for 4 min and chased for the indicated time periods. pH was calculated
by the ratio of 490 nm/440 nm intensity of FITC compared to standard pH
solution.
Immunoblot Analysis
BM DCs were purified with CD11c MACS beads. Cell lysates (50 mg total
proteins) were run on SDS-PAGE and blotted to PVDF membrane and
developed with the antibodies against cathepsin B (Fl-339), D (R-20), L (C-18),S (M-19), and Ii (FL-296) (Santa Cruz) and b actin (Sigma). For monitoring
cytosolic autophagy, rabbit anti-LC3 antibody (Novus) and mouse anti-p62
(2C11, Abnova) were used.
Protein Degradation Assay
Protease activity was measured with a previously described in vitro degrada-
tion assay (Jancic et al., 2007). In brief, 1 mg of phagosome extract was incu-
bated at 37C for 5 hr in the presence of 40 mM fluorogenic substrate (Bachem,
Weil am Rheim, Germany) for cathepsin B/L (Z-Phe-Arg-AMC) or for cathepsin
S (Z-Val-Val-Arg-AMC). The enzymatic reactions were performed in 200 ml
PBS with 0.5% Triton X-100 and 2 mM DTT at pH 5.5 or at pH 7.4 in a
96 flat-well plate. Substrate degradation was assayed fluorometrically with a
VICTOR 2 plate reader (Perkin Elmer).
SUPPLEMENTAL INFORMATION
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